FRANCISCO JAVIER
LÓPEZ LONGO
Forscher bis um 2019
University College London
Londres, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von University College London (2)
2020
-
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Respiratory Medicine, Vol. 8, Núm. 10, pp. 963-974
2016
-
Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry
Rheumatology (United Kingdom), Vol. 55, Núm. 7, pp. 1243-1250